Search bioRxivSearch

bioRxiv · 10.1101/2020.07.01.181826

Spatial cueing effects do not always index attentional capture: Evidence for a Priority Accumulation Framework

Abstract

In visual search, improved performance when a target appears at a recently cued location is taken as strong evidence that attention was shifted to this cue. Here, we provide evidence challenging the canonical interpretation of spatial-cueing (or cue-validity) effects and supporting the Priority Accumulation Framework (PAF). According to PAF, attentional priority accumulates over time at each location until the search context triggers selection of the highest-priority location. Spatial-cueing effects reflect how long it takes to resolve the competition and can thus be observed even when attention was never shifted to the cue. Here, we used a spatial-cueing paradigm with abruptly onset cues and search displays varying in target-distractor similarity. We show search performance on valid-cue trials deteriorated the more difficult the search, a finding that is incompatible with the standard interpretation of spatial-cueing effects. By using brief displays (Experiment 1) and by examining the effect of search difficulty on the fastest trials (Experiment 2), we invalidate alternative accounts invoking post-perceptual verification processes (Experiment 1) or occasional failures of the onset cue to capture attention (Experiment 2). In Experiment 3, we used a combination of the spatial-cueing and dot-probe paradigms. We show that the events that occurred in both the cue and search displays affected attentional distribution, and that the relative attentional priority weight that accumulated at the target location determined how easily the competition was resolved. These findings fully support PAFs predictions. Public significance statementMany studies aim at establishing whether certain objects mandatorily capture our attention. Here, we show that there is no "yes-or-no" answer to this question because the context in which an object appears determines whether this object captures attention. We show that our attention is not shifted to the highest-priority object at any given time: instead, information about priority is collected across time until some signal indicates that the appropriate moment for deploying our attention has arrived. Striking failures to notice conspicuous events routinely illustrate how limited our attentional system is: we can attend to very few objects at any given time, and probably to just one. In natural conditions, when we move the focus of our attention from one object to another, we also shift our gaze towards the attended location: this allows us to place the object of most interest in the center of our fovea, which maximizes the quality of its perceptual processing. Tracking the locus of such overt attention is easily achieved by using eye-tracking devices. However, in order to isolate the benefits of attention from the benefits of visual acuity, one must study covert attention - that is, attentional shifts in the absence of eye movements. These shifts are not directly observable and must therefore be inferred using indirect measures of processing.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Darnell, M., Lamy, D.. 2020-07-02. Spatial cueing effects do not always index attentional capture: Evidence for a Priority Accumulation Framework. https://doi.org/10.1101/2020.07.01.181826

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience